HomeKNE • CVE
Follow
Kane Biotech Inc
Previous close
$0.10
Day range
$0.10 - $0.11
Year range
$0.050 - $0.14
Market cap
13.21M CAD
Avg Volume
64.06K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 717.85K | 25.57% |
Operating expense | 1.51M | 34.59% |
Net income | -1.38M | -36.28% |
Net profit margin | -192.02 | -8.53% |
Earnings per share | — | — |
EBITDA | -1.13M | -43.57% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.62M | 29.23% |
Total assets | 6.01M | -8.86% |
Total liabilities | 13.02M | 31.25% |
Total equity | -7.01M | — |
Shares outstanding | 131.84M | — |
Price to book | -1.43 | — |
Return on assets | -51.52% | — |
Return on capital | -148.11% | — |
Cash Flow
Net change in cash
(CAD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -1.38M | -36.28% |
Cash from operations | -715.27K | 27.88% |
Cash from investing | -32.79K | 53.60% |
Cash from financing | 1.23M | 670.63% |
Net change in cash | 477.04K | 137.35% |
Free cash flow | -481.22K | 43.50% |
About
Founded
2001
Headquarters
Website